A bioenergetic basis for multiorgan dysfunction in sepsis
Elisa JenthoiD, Temitope Wilson AdemolueiD, Hessel Peters SengersiD, Joe M. ButleriD, Linlin XuiD, Sharad RastogiiD, Jamil Zola KitokoiD, Sara Emanuela PagnottaiD, Bernhard DrotleffiD, Pedro FaíscaiD, Valentyna O. PolishchukiD, Miguel MesquitaiD, Paul HorniD, Uta Barbara Metzing, Sílvia CardosoiD, Gilles MithieuxiD, Michael W BaueriD, Osoul ChouchaneiD, Sebastian WeisiD, Gianni PanagiotouiD, Christian von LoeffelholziD, Tom van der PolliD, Miguel Parreira SoaresiD
Abstract
Sepsis is a life-threatening multiorgan dysfunction that develops from a maladaptive host response to infection1. With an estimated 49 million cases per year and [~]11 million related deaths2, sepsis is a global WHO health priority3. Failure to overcome sepsis morbidity and lethality4,5 calls for alternative therapeutic approaches6-8. Here we report that adipocyte lipolysis is vital to prevent the pathogenesis of sepsis in mice. This protective response is evolutionary conserved, producing a plasma lipidomic profile9,10 that reflects on the severity of clinical sepsis. Mechanistically, adipocyte lipolysis fuels energy metabolism to sustain adaptive thermoregulation to infection, via insulin production and insulin receptor (INSR) signaling in adipocytes. This metabolic-based defense strategy does not impact on bacterial burden, establishing disease tolerance to infection11-14. In conclusion, adipocyte lipolysis induces insulin to rewire energy metabolism and support organ function in response to infection.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lipid mobilization establishes metabolic tolerance and prevents autonomic collapse in infection
Ankita Sarkar, Shangkui Xie, … Suraj J. Patel·bioRxiv·Apr 21, 2026
- Transient protein phosphorylation promotes disease tolerance to sepsis
Wolfgang Vivas, Johannes Roth, … Sebastian Weis·bioRxiv·Jun 10, 2026
- Hepatic IRE1 Protects Against Septic Cardiac Failure
M. Li, R. R. Berton, … L. Yang·bioRxiv·Mar 14, 2023
- SEPSIS-INDUCED LIPID DROPLET ACCUMULATION ENHANCES ANTIBACTERIAL INNATE IMMUNITY
Filipe Santos Pereira-Dutra, Julia Cunha Santos, … Patrícia Torres Bozza·bioRxiv·Jan 29, 2025
- Microbiota-dependent inflammation promotes metabolic disorder via NF-kB-mediated inhibition of SREBP in Drosophila adipocytes
B. Charroux, j. royet·bioRxiv·Apr 28, 2021
- Dichloroacetate reverses sepsis-induced hepatic metabolic dysfunction
R. Mainali, M. Zabalwi, … M. A. Quinn·eLifePeer-reviewed·Feb 22, 2021